SAPHCLAZIDE-30 Gliclazide 30mg Tablet 1's
SAPHCLA-N7X6VW
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications
Diabetes mellitus, type 2
Administration
Should be taken with food.
Contraindications
Hypersensitivity to gliclazide, other sulfonylureas or sulfonamides. Type 1 diabetes mellitus, diabetic coma and pre-coma, diabetic ketoacidosis. Severe hepatic or renal impairment. Pregnancy and lactation. Concomitant use with miconazole.
Special Precautions
Patient with risk factors for hypoglycaemia (e.g. malnourished, severe or poorly compensated endocrine disorders, severe vascular disease), G6PD-deficiency, porphyria, stress-related states (e.g. severe trauma, fever, infection, surgery). Mild to moderate hepatic or renal impairment. Elderly.
Storage
Store between 15-30°C.
MedsGo Class
Antidiabetic Agents
Features
Brand
Saphclazide-30
Full Details
Dosage Strength
30 mg
Drug Ingredients
- Gliclazide
Drug Packaging
Tablet 1's
Generic Name
Gliclazide
Dosage Form
Tablet
Registration Number
DRP-11488
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply